{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-023858","form_type":"8-K","ticker":"AVAH","cik":"0001832332","company_name":"Aveanna Healthcare Holdings, Inc.","filed_at":"2022-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.516504+00:00","generated_at":"2026-06-22T01:53:35.758131+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Aveanna Q3 revenue $443M (+7.7% YoY), adj EBITDA $24.7M vs $45.8M YoY","bullets":["Revenue $443.0M, up 7.7% YoY; gross margin 30.4% vs 34.0% YoY.","Adjusted net loss per diluted share $(0.03) vs adjusted net income $0.11 in prior year.","Adjusted EBITDA $24.7M (5.6% of revenue) versus $45.8M (11.1% of revenue) in Q3 2021.","CEO cites difficult labor environment and HHH system conversion impact; expects return to normal into 2023.","Liquidity: $63.7M cash, $182.4M revolver available, $140M DDTL for acquisitions."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-023858","json":"https://secwatch.observer/filing/0000950170-22-023858.json","markdown":"https://secwatch.observer/filing/0000950170-22-023858.md","text":"https://secwatch.observer/filing/0000950170-22-023858.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832332/000095017022023858/0000950170-22-023858-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832332/000095017022023858/avah-20221109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T01:53:35.758131+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e5bcb71b4d196c1455090ad3557766ee676d2132","claim":"Aveanna Healthcare Holdings, Inc. reported three and nine-month periods ended October 1, 2022 results: revenue $1,336.5 million.","evidence_excerpt":"Revenue was $443.0 million for the three-month period ended October 1, 2022, as compared to $411.3 million for the three-month period ended October 2, 2021, an increase of $31.7 million, or 7.7%.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832332/000095017022023858/0000950170-22-023858-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and nine-month periods ended October 1, 2022"},{"label":"Revenue","value":"$1,336.5 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"e5bcb71b4d196c1455090ad3557766ee676d2132","claim":"Aveanna Healthcare Holdings, Inc. reported three and nine-month periods ended October 1, 2022 results: revenue $1,336.5 million.","evidence_excerpt":"Revenue was $1,336.5 million for the nine-month period ended October 1, 2022, as compared to $1,264.5 million for the nine-month period ended October 2, 2021, an increase of $72.0 million, or 5.7%.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832332/000095017022023858/0000950170-22-023858-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and nine-month periods ended October 1, 2022"},{"label":"Revenue","value":"$1,336.5 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}